Skip to main content
. 2019 Jan 25;10(2):61. doi: 10.1038/s41419-019-1341-7

Fig. 6. Decreased plasma miR-142-3p level in STEMI patients undergoing pPCI with no-reflow.

Fig. 6

a Quantitative real-time polymerase chain reaction (qRT-PCR) showed that miR-142-3p expression level was decreased in the plasma of STEMI patients undergoing pPCI without no-reflow (n = 214) when compared with STEMI patients undergoing pPCI with no-reflow (n = 41). b The receiver–operator characteristic curve for the plasma miR-142-3p acts as a potential biomarker for STEMI patients undergoing pPCI with no-reflow